The Novel Arylamidine T-2307 Maintains In Vitro and In Vivo Activity against Echinocandin-Resistant Candida albicans

We evaluated the in vitro and in vivo activities of the investigational arylamidine T-2307 against echinocandin-resistant Candida albicans. T-2307 demonstrated potent in vitro activity, and daily subcutaneous doses between 0.75 and 6 mg/kg of body weight significantly improved survival and reduced f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Wiederhold, Nathan P., Najvar, Laura K., Fothergill, Annette W., Bocanegra, Rosie, Olivo, Marcos, McCarthy, Dora I., Kirkpatrick, William R., Fukuda, Yoshiko, Mitsuyama, Junichi, Patterson, Thomas F.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2015
Materias:
Experimental Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335842/
https://ncbi.nlm.nih.gov/pubmed/25451054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04228-14
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares